US Patent Litigations are now available. Check here

EP3175863

BIOMARIN PHARMACEUTICAL
Application Number
EP16192229A
Filing Date
May 20, 2010
Status
Granted And Under Opposition
Oct 29, 2021
Grant Date
Dec 1, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3175863B1 was granted on Dec 1, 2021 by Biomarin Pharmaceutical The patent is currently Granted And Under Opposition.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS5252714
N/A
OppositionUS5824784
N/A
OppositionWO2009067639
N/A
OppositionUS6743425
N/A
OppositionUS2007197434
N/A
OppositionWO2006005140
N/A
OppositionEP0477971
N/A
OppositionUS5340920
N/A
OppositionWO02098446
N/A
OppositionEP1333036
N/A
OppositionWO2004043396
N/A
OppositionEP0769554
N/A
OppositionUS2008312142
N/A
OppositionWO2009086166
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.